Spero Therapeutics, Inc. Taxes Payable, Current
Spero Therapeutics, Inc. (SPRO) had Taxes Payable, Current of $163.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:TaxesPayableCurrent · last filed 2026-08-12
- 2026-06-30: Taxes Payable, Current $163.00K.
- 2026-03-31: Taxes Payable, Current $163.00K.
- 2025-12-31: Taxes Payable, Current $383.00K.
- 2025-09-30: Taxes Payable, Current $163.00K.
| Period end | Taxes Payable, Current |
|---|---|
| 2026-06-30 | $163.00K 10-Q · filed 2026-08-12 |
| 2026-03-31 | $163.00K 10-Q · filed 2026-05-13 |
| 2025-12-31 | $383.00K 10-Q · filed 2026-08-12 |
| 2025-09-30 | $163.00K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $163.00K 10-Q · filed 2025-08-12 |
| 2025-03-31 | $174.00K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $174.00K 10-K · filed 2026-03-26 |
| 2024-09-30 | $97.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $387.00K 10-Q · filed 2024-08-05 |
| 2024-03-31 | $387.00K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $387.00K 10-K · filed 2025-03-27 |
| 2023-09-30 | $2.21M 10-Q · filed 2023-11-13 |
| 2022-12-31 | $0.00 10-K · filed 2024-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 |